Skip to main content

Table 1 Baseline Clinical Characteristics of 52 Patients.

From: Comparison of VerifyNow-P2Y12 test and Flow Cytometry for monitoring individual platelet response to clopidogrel. What is the cut-off value for identifying patients who are low responders to clopidogrel therapy?

 

N (%) or mean ± SD

Age (years)

64 ± 11

Male

39 (75)

Ejection fraction %

53 ± 8

Body mass index >30, kg/m2

7 (15)

Hematocrit %

36.6 ± 8.3

Platelet count (× 103/μL)

251 ± 127

Risk Factors

 

Diabetes

14 (28)

-Insulin dependent Diabetes

6 (12)

Hypertension

32 (64)

Hypercholesterolemia

31 (62)

Current smoking

5 (10)

History

 

Previous MI

23 (46)

Previous PCI

16 (48)

Previous CABG

6 (12)

Chronic renal failure†

2 (4)

Coronary Artery Disease n, (%)

 

1 vessel

12 (28)

2 vessel

29 (55)

3 vessel

18 (34)

Therapy n, (%)

 

Beta-blockers

32 (61)

ACE-inhibitors

30 (57)

Nitrates

10 (19)

Ca-antagonists

17 (32)

Statins

38 (71)

  1. Values are expressed as means ± SDs or number (percentages) of patients.
  2. MI = acute myocardial infarction; PCI = percutaneous coronary intervention; CABG = coronary artery bypass graft. †Defined as the presence of previously documented renal failure and/or a baseline serum creatinine level > 2 mg/dl.